The Upstate Global Health Institute is working with a sponsor to develop a new oral drug for RSV. The purpose of this study is to see if the drug is safe and effective when treating RSV. We are seeking participants who are experiencing at least 2 of the following respiratory symptoms such as; cough, cough with phlegm, wheezing or shortness of breath rated as MODERATE. Along with these symptoms the following must pertain to participants:
- Patients 18 years of age
- The patient has a condition that predisposes them to complications after RSV infection, such as:
- 75 years old or older
- 65-74 years old with CHF and/or COPD
-
New onset or worsening symptoms which include feeling feverish, headache, neck pain, fatigue, loss of appetite, interrupted sleep, body aches, sore throat, nasal congestions, cough, cough with phlegm, wheezing or shortness of breath no more than 72 hours prior to first visit at research clinic.